Clinical Trials Logo

Diabetic Neuropathy, Painful clinical trials

View clinical trials related to Diabetic Neuropathy, Painful.

Filter by:

NCT ID: NCT06152887 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Noninvasive Cortical Neurostimulation For Diabetic Neuropathic Pain

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

To investigate whether transcranial direct current stimulation can alleviate pain and sensory related disturbances in individuals with type 1 diabetes and peripheral neuropathy through neuromodulation of the CNS as compared to sham treatment.

NCT ID: NCT05920434 Completed - Clinical trials for Diabetic Neuropathy, Painful

The Effect of Foot Reflexology and Foot Bath on Paın And Qualıty of Lıfe Applıed to Dıabetıc Neuropathıc Paın

Start date: July 19, 2020
Phase: N/A
Study type: Interventional

Introduction: Pain relief in diabetic neuropathy is one of the main goals of treatment. Foot reflexology and foot bath, which are two of the important applications of holistic approaches, reduce pain and can significantly increase the quality of life. Objective: In the current study, it was aimed to examine the effects of foot reflexology and foot bath applied to diabetic individuals with neuropathic pain on pain and quality of life. Method: In this randomized controlled study, the sample was randomized into three groups: (I) Foot reflexology (n: 30), (II) Foot bath (n: 30), and (III) Control (n: 30). The "Patient Information Form", "DN4 Pain Questionnaire", "Neuropathic Pain Impact on Quality-of-Life questionnaire (NePIQoL)", and "Visual Analog Scale (VAS)" were used to collect research data. In the study, a protective sensory examination was also performed with the Semmes-Weinstein Monofilament (SWM) Test and the Vibration Test (128 Hz diapason). Apart from these, foot care training was given to all patients included in the practice groups as the role of the diabetes nurse, based on the diabetic foot care training prepared by the Turkish Diabetes Association.

NCT ID: NCT05917249 Completed - Clinical trials for Diabetic Neuropathy, Painful

Efficacy of Noninvasive Radiofrequency in Attenuating Diabetic Neuropathic Pain

Start date: June 7, 2023
Phase: N/A
Study type: Interventional

Peripheral neuropathy increases the prevalence of diabetic foot ulcers following a decrease in foot sensation. Therefore, the treatment of this disorder is very important.

NCT ID: NCT05670600 Completed - Clinical trials for Diabetic Neuropathy, Painful

The Effect of Foot and Ankle Exercise on Pain and Quality of Life in Patients With Diabetic Neuropathy

Start date: July 19, 2021
Phase: N/A
Study type: Interventional

The study will be carried out to determine the effect on pain and quality of life between the groups that received and did not receive foot and ankle exercise training.

NCT ID: NCT05623111 Recruiting - Clinical trials for Diabetic Neuropathy, Painful

Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities

PINBOT
Start date: August 1, 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to test perineural injections (injections around a nerve) of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs. The main questions it aims to answer are: - Is the treatment safe and effective? - Does the treatment affect participants quality of life, depression, physical activity, daily life, and sensation? Participants will be treated every 12 weeks, for a total of 24 weeks, with either incobotulinumtoxin-A or a placebo.

NCT ID: NCT05301816 Recruiting - Clinical trials for Diabetic Neuropathy, Painful

PDN Post Market, Multicenter, Prospective, Global Clinical Study

PDN-PM
Start date: July 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.

NCT ID: NCT05029297 Completed - Clinical trials for Diabetic Neuropathy, Painful

Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.

Start date: November 4, 2010
Phase: Phase 3
Study type: Interventional

Clinical trial of "line extension" of drug ARAFARMADOL® 0.075% cream in a new formulation in topical solution applicable in roll-on and with the same therapeutic indications approved for the cream.

NCT ID: NCT04988321 Completed - Clinical trials for Diabetic Neuropathy, Painful

Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms

Start date: September 3, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effects of a newer form of non-invasive brain stimulation (called transcranial magnetic stimulation or TMS) as a treatment in patients with painful diabetic neuropathy to examine its effects on their understanding of their pain experience.

NCT ID: NCT04469270 Active, not recruiting - Clinical trials for Diabetic Neuropathy, Painful

Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy

REGAiN-1A
Start date: October 9, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of intramuscular (IM) administration of Engensis on pain in participants with painful diabetic peripheral neuropathy (DPN) in the feet and lower legs, as compared to Placebo, as a second Phase 3, well controlled study, sufficient in supporting the efficacy and safety of Engensis.

NCT ID: NCT04055090 Completed - Clinical trials for Painful Diabetic Neuropathy

Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Start date: February 4, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to explore the overall safety profile and durability of efficacy of Engensis (VM202) in painful diabetic peripheral neuropathy. All subjects still in follow-up for the VMDN-003 study or who have completed the Day 270 visit within the prior 90 days will be approached to enroll in the long-term safety extension study.